Evaluating the Impact of <scp>CYP1A2</scp> Inhibition on the Pharmacokinetics of Savolitinib: A Phase 1 Open‐Label Study

Kowser Miah, Jitendar Reddy, Pradeep Sharma, Ike Igwegbe, Simon Nelson, Caitlin Muldoon, Ronald Goldwater, Karthick Vishwanathan

Open source

DOI
10.1002/prp2.70321
Published
2026-09-22
Container
Pharmacology Research &amp; Perspectives
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/prp2.70321,
  title = {Evaluating the Impact of
                    <scp>CYP1A2</scp>
                    Inhibition on the Pharmacokinetics of Savolitinib: A Phase 1 Open‐Label Study},
  author = {Kowser Miah and Jitendar Reddy and Pradeep Sharma and Ike Igwegbe and Simon Nelson and Caitlin Muldoon and Ronald Goldwater and Karthick Vishwanathan},
  year = {2026},
  journal = {Pharmacology Research \&amp; Perspectives},
  doi = {10.1002/prp2.70321},
  url = {https://doi.org/10.1002/prp2.70321}
}

RIS

TY  - JOUR
TI  - Evaluating the Impact of
                    <scp>CYP1A2</scp>
                    Inhibition on the Pharmacokinetics of Savolitinib: A Phase 1 Open‐Label Study
AU  - Kowser Miah
AU  - Jitendar Reddy
AU  - Pradeep Sharma
AU  - Ike Igwegbe
AU  - Simon Nelson
AU  - Caitlin Muldoon
AU  - Ronald Goldwater
AU  - Karthick Vishwanathan
PY  - 2026
JO  - Pharmacology Research &amp; Perspectives
DO  - 10.1002/prp2.70321
UR  - https://doi.org/10.1002/prp2.70321
ER  - 

APA

Miah, K., Reddy, J., Sharma, P., Igwegbe, I., Nelson, S., Muldoon, C., Goldwater, R., & Vishwanathan, K. (2026). Evaluating the Impact of <scp>CYP1A2</scp> Inhibition on the Pharmacokinetics of Savolitinib: A Phase 1 Open‐Label Study. Pharmacology Research &amp; Perspectives. https://doi.org/10.1002/prp2.70321

Source records